Directors and Officers (D&O) liability insurance is not a static product. In the U.S. market, insurers and insureds routinely use endorsements (amendments) to tailor D&O policies to a corporation’s risk profile, jurisdictional exposure, and board governance preferences. This article explains how endorsements modify the core D&O document, demonstrates the commercial impact in major U.S. markets (New York, California, Texas, Illinois), and gives actionable guidance for negotiating endorsements with carriers such as Chubb, AIG and Travelers.
Why endorsements matter for D&O buyers (commercial focus)
- Endorsements change contract terms — not just formatting — and can alter who is protected, the scope of coverage, allocation rules, and settlement authority.
- For middle-market and public companies, small changes can produce material shifts in premium, retentions, and coverage priorities.
- Market dynamics matter: U.S. D&O market conditions since 2020 have driven tighter wordings and higher premiums in many sectors. According to Marsh and other market observers, D&O rate pressure and underwriting scrutiny remain elevated for many classes of risk (securities exposures, tech, SPACs, and high-profile M&A targets). (See market commentary from Marsh.)[1]
[1] Marsh market commentary: https://www.marsh.com/us/insights/research/global-insurance-market-index.html
Common endorsement categories and the core policy sections they alter
Below are the most common endorsement types and the core D&O policy components they typically change:
- Definition amendments (e.g., “Insured Person” clarifications)
- Affects: Named Insured/Insured Persons sections, exclusions, and indemnity triggers.
- Exclusion endorsements (e.g., SEC investigation, prior acts, cyber-related carve-outs)
- Affects: Exclusions and insuring agreements; can eliminate coverage for high-cost exposures.
- Retention and allocation endorsements
- Affects: Deductible/retention clauses and allocation between entity and individual coverage (Side A/B/C).
- Severability / consent / cooperation amendments
- Affects: Severability provisions, consent-to-settle language, cooperation/advancement of defense.
- Policy limit / Sublimit adjustments
- Affects: Limits and schedule of coverage, sometimes adding sublimits for investigations or derivative suits.
- Jurisdiction- or venue-specific endorsements
- Affects: Choice of law, forum selection, and applicability for suits in New York, California, Delaware, etc.
How endorsements change the three pillars (A/B/C) of D&O
Endorsements can reallocate how the policy responds across Side A (individual director coverage), Side B (entity indemnification), and Side C (entity securities claims). The table below summarizes typical endorsement impacts:
| Endorsement Type | Typical Change | Impacted Pillar(s) | Likely Commercial Effect |
|---|---|---|---|
| Side A Enhancement Endorsement | Adds non-indemnifiable loss protection, broader advancement | Side A | Higher premium (~10–30% depending on risk); protects individuals where company cannot indemnify |
| Carve-out / Exclusion (e.g., SEC investigations) | Removes coverage for certain regulatory or criminal acts | Side B / Side C | Lowers insurer exposure; reduces premium modestly but increases uncovered risk |
| Allocation Clarification | Specifies formula for allocating defense and settlement costs between insureds and entity | Sides A/B/C | Reduces allocation disputes; may affect defense cost advance timing; neutral or small premium impact |
| Consent-to-Settle Tightening | Requires insured consent for settlements | All | Raises insurer negotiation leverage; potential litigation risk; may reduce premium slightly |
| Cyber or Privacy Sublimit | Adds sublimit for cyber-related D&O claims | Side C | May raise overall premium but provides problematic exposure management |
Real-world pricing context (U.S. focus)
Pricing for D&O varies widely by company size, industry, public vs. private status, and location. Typical current ranges (U.S. market, 2024–2025 environment; carriers include Chubb, AIG, Travelers):
- Small private companies (e.g., $1M limit, low litigation exposure): $1,000–$5,000 annual premium. (Source: Insureon / Policygenius)[2][3]
- Mid-market companies (higher revenue, more complex risks): $25,000–$100,000+ depending on limits and exposures.
- Public companies or high-risk industries (technology, biotech): $250,000 to several million for primary limits; excess layers add substantially.
Examples:
- Chubb and AIG regularly compete for mid-market accounts in New York and San Francisco; brokers report initial quotes for a $5M shared-limit tower for a mid-size tech company could start around $75,000–$150,000, influenced by endorsement choices (e.g., Side A enhancement or securities carve-outs).
- For a privately held firm in Houston (oil & gas), adding a regulatory exclusion for environmental liabilities through an endorsement can lower the premium but expose the company to uninsured defense costs if an environmental enforcement action targets directors.
[2] Insureon D&O cost guidance: https://www.insureon.com/d-and-o-insurance/cost
[3] Policygenius D&O cost overview: https://www.policygenius.com/business-insurance/d-and-o-insurance-cost/
Endorsement negotiation: practical steps for boards and risk managers
- Map exposures before negotiations
- Identify litigation history, pending investigations, and jurisdictional exposures (e.g., Delaware corporate law, California consumer suits, New York securities litigation).
- Prioritize endorsements that protect directors
- Ask for Side A enhancements and advancement provisions if the company may be unable to indemnify in a bankruptcy or insolvency scenario.
- Quantify trade-offs
- Decide whether removing certain exclusions (e.g., SEC or consumer privacy) is worth premium increases. Use broker market leverage with carriers like Travelers, Chubb, and AIG.
- Insist on clear allocation language
- Ambiguous allocation clauses create costly disputes. Nail down formulae for defense cost splitting and settlement allocation.
- Negotiate consent-to-settle carefully
- Boards should avoid blanket insurer settlement authority that can expose directors to reputational harm or forced admissions.
Red flags and endorsements to avoid or approach cautiously
- Broad prior-acts exclusions that retroactively eliminate coverage for in-progress matters.
- Overly broad criminal act or fraud carve-outs when the company lacks a strong indemnity posture.
- Consent-to-settle provisions that allow the insurer to settle without board input in securities suits.
- Restrictions on advancement or cooperation that delay defense cost payments.
See more on negotiating policy clauses in: Policy Wording Red Flags: Key Clauses to Negotiate in Your Directors and Officers (D&O) Liability Insurance.
Case scenarios by U.S. location
- New York (financial services): high securities/regulatory exposure — endorsements limiting regulatory defense (SEC/DOJ) will materially raise uninsured risk. Demand Side A enhancements.
- California / San Francisco (tech): cyber/privacy carve-outs are common. Consider cyber-D&O sublimits or difference-in-conditions endorsements that align D&O and cyber programs.
- Texas (energy): environmental exclusions can lower premium but create 1st-party defense gaps. Negotiate shared defense cost allocation.
- Illinois / Chicago (manufacturing): derivative suits often follow corporate transactions — prior-acts endorsements and M&A-related carve-outs must be carefully reviewed.
Quick checklist before signing an endorsement
- Does it change definitions for “Insured Person” or “Loss”? If yes, review with coverage counsel.
- Does it restrict Side A advancement or add a subrogation right against directors?
- Are sublimits created for high-frequency exposures (investigations, cyber)?
- Is allocation language objective and enforceable?
- Has the broker compared quotes from at least two carriers (e.g., Chubb vs. AIG vs. Travelers)?
For a deep dive on structures and insuring agreements that endorsements interact with, consult: Breaking Down a Directors and Officers (D&O) Liability Insurance Policy: Insuring Agreements Explained and Side A, B & C Explained: The Three Pillars of a Directors and Officers (D&O) Liability Insurance Policy.
Conclusion
Endorsements are the primary tool to tailor D&O coverage to the commercial realities of U.S. companies in New York, California, Texas, Illinois and beyond. While endorsements can reduce premium or narrow risk for insurers, they often transfer exposures back to the corporation or its directors. Treat endorsement negotiation as strategic: quantify trade-offs, prioritize director protection (Side A), insist on clear allocation language, and use broker leverage among major carriers to obtain favorable terms.
External resources and market guidance:
- Marsh market commentary on D&O market conditions: https://www.marsh.com/us/insights/research/global-insurance-market-index.html
- Insureon (D&O cost examples): https://www.insureon.com/d-and-o-insurance/cost
- Policygenius (D&O cost overview): https://www.policygenius.com/business-insurance/d-and-o-insurance-cost/